What is the most appropriate management for a 5‑month‑old infant with a 10‑day history of cough, cyanotic episodes, post‑tussive vomiting, and marked lymphocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Azithromycin is the Most Appropriate Management

For this 5-month-old infant with classic pertussis presentation (paroxysmal cough, post-tussive vomiting, cyanotic episodes, and marked lymphocytosis), azithromycin is the definitive treatment. The answer is A. Azithromycin.

Clinical Reasoning

This infant presents with the pathognomonic triad of pertussis:

  • Paroxysmal cough with post-tussive vomiting (classic whooping cough)
  • Cyanotic episodes (indicating severe disease)
  • Marked lymphocytosis (WBC 27,000/L with 80% lymphocytes = ~21,600 lymphocytes/L)

The 10-day history places this in the catarrhal-to-paroxysmal phase where antimicrobial therapy is most critical to reduce transmission and potentially modify disease severity, particularly in this vulnerable age group where mortality risk is highest 1.

Why Azithromycin is the Correct Choice

According to CDC guidelines, azithromycin is the preferred macrolide for infants aged <6 months 1. The specific dosing for this 5-month-old is:

  • 10 mg/kg per day for 5 days (single daily dose) 1

Advantages Over Other Macrolides in This Age Group:

  • Safer than erythromycin: Erythromycin carries significant risk of infantile hypertrophic pyloric stenosis (IHPS) in infants <1 month and is less well-tolerated in young infants 1
  • Better tolerability: Fewer gastrointestinal side effects compared to erythromycin 1
  • Convenient dosing: Once-daily administration improves adherence versus erythromycin's 4-times-daily regimen 1
  • Shorter course: 5 days versus 14 days for erythromycin 1

Why Other Options Are Incorrect

B. Ceftriaxone

  • No activity against Bordetella pertussis
  • Cephalosporins are not effective for pertussis treatment
  • This would be appropriate for bacterial pneumonia or meningitis, but not pertussis

C. Nebulized Salbutamol

  • Does not treat the underlying infection
  • Bronchodilators have no role in pertussis management
  • The cough is due to toxin-mediated airway damage, not bronchospasm
  • May provide minimal symptomatic relief but does not address the disease

D. Corticosteroids

  • No proven benefit in pertussis
  • Not recommended in guidelines [1-1
  • The pathophysiology involves bacterial toxins, not primarily inflammation amenable to steroid therapy

Critical Management Considerations

Severity Assessment

This infant has severe pertussis based on:

  • Age <6 months (highest risk group for mortality) 1
  • Cyanotic episodes (indicating hypoxemia)
  • Marked lymphocytosis (>20,000 lymphocytes/L is associated with severe disease and pulmonary hypertension risk) 2, 3, 4

Additional Management Beyond Antibiotics

While azithromycin is the answer to this question, recognize that this infant requires:

  • Hospitalization with intensive monitoring for apnea, hypoxemia, and feeding difficulties
  • Close monitoring for malignant pertussis (extreme leukocytosis >50,000/L with lymphocytosis can cause pulmonary hypertension and death) 2, 3, 4
  • Supportive care: Oxygen, gentle suctioning, minimal stimulation to prevent paroxysms
  • Contact tracing and prophylaxis for household members 1

Common Pitfalls to Avoid

  1. Delaying antibiotic therapy: Even though antibiotics primarily reduce transmission rather than dramatically alter clinical course once paroxysmal phase begins, they should be started immediately in infants due to high mortality risk 1

  2. Using erythromycin instead of azithromycin: While erythromycin is cheaper and was historically first-line, azithromycin is specifically preferred for infants <6 months due to better safety profile 1

  3. Treating as bronchiolitis or asthma: The marked lymphocytosis and post-tussive vomiting distinguish pertussis from viral bronchiolitis

  4. Underestimating severity: Infants <6 months with pertussis and lymphocytosis >20,000/L require intensive monitoring as they can rapidly deteriorate with pulmonary hypertension 2, 3, 4

  5. Missing the diagnosis entirely: In the acute care setting, lymphocytosis in an infant with cough should immediately raise suspicion for pertussis 5, 6

Related Questions

In a 10‑month‑old infant with paroxysmal nighttime cough, thick nasal secretions, and post‑tussive vomiting but without a classic inspiratory whoop, what is the recommended management?
In a 10‑month‑old infant with a cough that worsens in the evenings and at night, accompanied by paroxysmal coughing, thick nasal secretions, and post‑tussive vomiting, what is the recommended management?
In a 2‑month‑old infant with a white‑blood‑cell count of 16 000/µL that is predominantly lymphocytic, what is the appropriate evaluation and management?
What is the appropriate management for a 5-month-old infant weighing 4.2 kg who presents with a cough?
What is the appropriate evaluation and management for a 32‑year‑old man presenting with right‑leg cramps and leukocytosis (white blood cell count 12.7 ×10⁹/L) with an absolute neutrophil count of 10,688/µL?
What is the appropriate management for a 6-year-old child with severe ear pain that prevents examination of the ear?
What is the appropriate dosing regimen of Fevarin (fluvoxamine) for treating depression in an adult patient?
What is the most likely diagnosis, acute otitis media versus otitis externa?
Is the cyst sellar or suprasellar based on its position relative to the diaphragm sellae on thin-section MRI?
What is the appropriate enoxaparin dose for a 79-year-old woman weighing 60 kg with atrial fibrillation, given the proposed rate of 43 mL per hour?
Is the cyst located within the brain parenchyma or in the sellar/suprasellar region?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.